Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer

PURPOSE: Gene expression profiling assays are frequently used to guide adjuvant chemotherapy decisions in hormone receptor–positive, lymph node–negative breast cancer. We hypothesized that the clinical value of these new tools would be more fully realized when appropriately integrated with high-qual...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Oncol
Asıl Yazarlar: Kim, Hyun-seok, Umbricht, Christopher B., Illei, Peter B., Cimino-Mathews, Ashley, Cho, Soonweng, Chowdhury, Nivedita, Figueroa-Magalhaes, Maria Cristina, Pesce, Catherine, Jeter, Stacie C., Mylander, Charles, Rosman, Martin, Tafra, Lorraine, Turner, Bradley M., Hicks, David G., Jensen, Tyler A., Miller, Dylan V., Armstrong, Deborah K., Connolly, Roisin M., Fetting, John H., Miller, Robert S., Park, Ben Ho, Stearns, Vered, Visvanathan, Kala, Wolff, Antonio C., Cope, Leslie
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2016
Konular:
ORIGINAL REPORTS
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455310/
https://ncbi.nlm.nih.gov/pubmed/27998227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.67.7195
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller